Insulet Corporation (PODD)

Nasdaq Health Care Health Care Equipment S&P 500

$146.51

-9.61 (-6.16%)

Close of Nov 06, 2026 · end-of-day data

Source: Insulet Corporation's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$366.99M	$463.80M	$563.80M	$738.20M	$904.40M	$1.04B	$1.06B	$1.70B	$2.07B	$2.71B
Cost of revenue	$155.90M	$186.60M	$193.60M	$257.90M	$322.10M	$346.70M	$499.70M	$537.20M	$625.90M	$768.20M
Gross profit	$211.09M	$277.20M	$370.20M	$480.30M	$582.30M	$752.10M	$805.60M	$1.16B	$1.45B	$1.94B
Research & development	$55.71M	$75.70M	$94.80M	$132.30M	$146.80M	$160.10M	$180.20M	$205.00M	$219.60M	$301.10M
Selling, general & admin	—	—	$248.00M	$298.00M	$384.00M	$466.00M	$587.80M	$734.80M	$917.20M	$1.17B
Operating income	-$10.70M	-$7.40M	$27.40M	$50.00M	$51.50M	$126.00M	$37.60M	$220.10M	$308.90M	$473.80M
Interest expense	$14.39M	$21.20M	$28.90M	$34.60M	$48.10M	$61.70M	$36.00M	$36.20M	$42.70M	$59.40M
Pre-tax income	-$26.82M	-$26.60M	$5.20M	$14.50M	$9.70M	$20.50M	$9.80M	$214.70M	$300.20M	$339.50M
Income tax	$392.00K	$200.00K	$1.90M	$2.90M	$2.90M	$3.70M	$5.20M	$8.30M	-$118.10M	$92.40M
Net income	-$28.88M	-$26.80M	$3.30M	$11.60M	$6.80M	$16.80M	$4.60M	$206.30M	$418.30M	$247.10M
EBITDA	$3.13M	$6.50M	$43.00M	$77.90M	$106.90M	$183.40M	$100.80M	$292.90M	$389.70M	$564.20M
EPS (basic)	$-0.48	$-0.46	$0.06	$0.19	$0.11	$0.25	$0.07	$2.96	$5.97	$3.51
EPS (diluted)	$-0.48	$-0.46	$0.05	$0.19	$0.10	$0.24	$0.07	$2.94	$5.78	$3.48
Diluted shares	57.25M	58.00M	61.01M	62.30M	65.95M	68.58M	69.91M	73.63M	73.89M	71.89M
Gross margin	57.5%	59.8%	65.7%	65.1%	64.4%	72.3%	76.3%	68.3%	69.8%	71.6%
Operating margin	-2.9%	-1.6%	4.9%	6.8%	5.7%	12.1%	3.6%	13.0%	14.9%	17.5%
Net margin	-7.9%	-5.8%	0.6%	1.6%	0.8%	1.6%	0.4%	12.2%	20.2%	9.1%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$137.17M	$272.58M	$113.90M	$213.70M	$907.20M	$806.40M	$689.80M	$704.20M	$953.40M	$716.10M
Short-term investments	—	—	$175.00M	$162.40M	$40.40M	$0	—	—	—	—
Receivables	$28.80M	$53.37M	$63.30M	$69.30M	$95.30M	$135.20M	$140.90M	—	—	$516.90M
Inventory	$35.51M	$33.79M	$71.40M	$101.00M	$154.30M	$303.20M	$346.80M	$402.60M	$430.40M	$452.60M
Total current assets	$369.96M	$537.17M	$461.30M	$591.00M	$1.25B	$1.33B	$1.31B	$1.58B	$1.89B	$1.91B
Goodwill	$39.68M	$39.80M	$39.60M	$39.80M	$39.80M	$39.80M	$51.70M	$51.70M	$51.50M	$51.60M
Total assets	$456.65M	$816.74M	$928.70M	$1.14B	$1.87B	$2.05B	$2.25B	$2.59B	$3.09B	$3.19B
Total current liabilities	$55.70M	$86.03M	$115.70M	$157.70M	$207.80M	$228.80M	$364.70M	$451.20M	$528.40M	$680.10M
Short-term debt	—	$0	—	$0	$15.60M	$25.10M	$27.50M	$49.40M	$83.80M	$18.40M
Long-term debt	$332.77M	$566.17M	$592.00M	$887.90M	$1.04B	$1.25B	$1.37B	$1.37B	$1.30B	$930.80M
Total debt	$332.77M	$566.17M	$592.00M	$887.90M	$1.06B	$1.27B	$1.40B	$1.42B	$1.38B	$949.20M
Total liabilities	$393.50M	$658.23M	$716.60M	$1.07B	$1.27B	$1.49B	$1.77B	$1.86B	$1.88B	$1.68B
Shareholders' equity	$63.10M	$158.50M	$212.10M	$75.90M	$603.60M	$556.30M	$476.40M	$732.70M	$1.21B	$1.52B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$15.91M	$41.30M	$35.90M	$98.40M	$84.00M	-$68.10M	$119.00M	$145.70M	$430.20M	$569.30M
Capital expenditures	$22.11M	$73.80M	$157.40M	$163.70M	$129.00M	$111.90M	$122.90M	$75.60M	$124.90M	$191.60M
Free cash flow	-$6.20M	-$32.50M	-$121.50M	-$65.30M	-$45.00M	-$180.00M	-$3.90M	$70.10M	$305.30M	$377.70M
Investing cash flow	-$178.01M	-$210.80M	-$184.50M	-$73.60M	$14.00M	-$82.70M	-$191.10M	-$119.40M	-$146.20M	-$222.70M
Financing cash flow	$176.57M	$304.50M	-$8.70M	$73.50M	$605.50M	$40.70M	-$40.30M	-$13.60M	-$28.00M	-$595.30M
Share buybacks	—	—	—	—	—	—	—	$0	$0	$59.60M
Stock-based compensation	$23.62M	$31.90M	$37.50M	$28.70M	$35.90M	$34.40M	$40.90M	$48.40M	$69.30M	$62.70M
Depreciation & amortization	$13.83M	$13.90M	$15.60M	$27.90M	$55.40M	$57.40M	$63.20M	$72.80M	$80.80M	$90.40M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$509.80M	$441.70M	$488.50M	$543.90M	$597.50M	$569.00M	$649.10M	$706.30M	$783.80M	$761.70M	$801.70M	$842.00M
Cost of revenue	$148.60M	$134.90M	$157.60M	$166.80M	$166.60M	$159.90M	$196.90M	$196.20M	$215.20M	$232.70M	$239.10M	$209.90M
Gross profit	$361.20M	$306.80M	$330.90M	$377.10M	$430.90M	$409.00M	$452.20M	$510.10M	$568.60M	$529.10M	$562.60M	$632.10M
Research & development	$42.00M	$50.20M	$53.90M	$54.90M	$60.60M	$59.60M	$73.40M	$77.20M	$90.90M	$89.70M	$88.10M	$91.60M
Selling, general & admin	$212.70M	$199.70M	$222.50M	$234.10M	$260.90M	$260.70M	$257.70M	$315.20M	$331.40M	$317.20M	$344.80M	$350.70M
Operating income	$106.50M	$56.90M	$54.50M	$88.10M	$109.30M	$88.80M	$121.10M	$117.70M	$146.30M	$122.10M	$129.70M	$189.80M
Interest expense	$6.70M	$10.70M	$11.00M	$12.40M	$8.60M	$9.20M	$19.60M	$15.60M	$14.90M	$14.70M	$13.50M	$16.20M
Pre-tax income	$107.90M	$54.90M	$51.10M	$82.90M	$111.40M	$48.20M	$28.40M	$122.80M	$140.20M	$113.00M	$118.70M	$177.20M
Income tax	$4.50M	$3.40M	-$137.50M	$5.40M	$10.70M	$12.70M	$5.90M	$35.20M	$38.50M	$21.90M	$23.70M	$36.10M
Net income	$103.30M	$51.50M	$188.60M	$77.50M	$100.70M	$35.40M	$22.50M	$87.60M	$101.60M	$91.10M	$95.00M	$141.10M
EBITDA	$125.30M	$75.70M	$73.70M	$109.40M	$130.80M	$110.50M	$143.40M	$139.70M	$170.70M	$148.30M	$156.40M	$218.00M
EPS (basic)	$1.48	$0.74	$2.69	$1.11	$1.44	$0.50	$0.32	$1.24	$1.44	$1.30	$1.37	$2.03
EPS (diluted)	$1.47	$0.73	$2.59	$1.08	$1.38	$0.50	$0.32	$1.24	$1.43	$1.30	$1.37	$2.03
Diluted shares	3.52M	73.74M	73.80M	73.95M	61.00K	74.11M	70.65M	70.66M	-406.00K	70.20M	69.40M	69.49M
Gross margin	70.9%	69.5%	67.7%	69.3%	72.1%	71.9%	69.7%	72.2%	72.5%	69.5%	70.2%	75.1%
Operating margin	20.9%	12.9%	11.2%	16.2%	18.3%	15.6%	18.7%	16.7%	18.7%	16.0%	16.2%	22.5%
Net margin	20.3%	11.7%	38.6%	14.2%	16.9%	6.2%	3.5%	12.4%	13.0%	12.0%	11.8%	16.8%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$704.20M	$751.20M	$821.00M	$902.60M	$953.40M	$1.28B	$1.12B	$757.40M	$716.10M	$480.40M	$534.90M	$584.40M
Receivables	—	—	—	—	—	—	—	—	$516.90M	$544.70M	$588.70M	$689.00M
Inventory	$402.60M	$430.60M	$430.90M	$444.90M	$430.40M	$440.80M	$446.90M	$446.30M	$452.60M	$462.50M	$484.80M	$552.10M
Total current assets	$1.58B	$1.62B	$1.75B	$1.86B	$1.89B	$2.33B	$2.28B	$1.86B	$1.91B	$1.71B	$1.85B	$2.04B
Goodwill	$51.70M	$51.70M	$51.70M	$51.70M	$51.50M	$51.50M	$51.70M	$51.60M	$51.60M	$51.60M	$51.60M	$51.60M
Total assets	$2.59B	$2.62B	$2.88B	$3.03B	$3.09B	$3.52B	$3.47B	$3.03B	$3.19B	$2.99B	$3.17B	$3.42B
Total current liabilities	$451.20M	$432.40M	$486.00M	$506.20M	$528.40M	$520.40M	$1.01B	$647.70M	$680.10M	$687.50M	$744.20M	$814.40M
Short-term debt	$49.40M	$38.90M	$37.90M	$42.00M	$83.80M	$83.10M	$460.70M	$79.90M	$18.40M	$18.60M	$18.90M	$19.10M
Long-term debt	$1.37B	$1.36B	$1.36B	$1.36B	$1.30B	$1.61B	$939.00M	$934.90M	$930.80M	$929.50M	$929.50M	$943.00M
Total debt	$1.42B	$1.40B	$1.40B	$1.40B	$1.38B	$1.70B	$1.40B	$1.01B	$949.20M	$948.10M	$948.40M	$962.10M
Total liabilities	$1.86B	$1.83B	$1.88B	$1.91B	$1.88B	$2.19B	$2.01B	$1.65B	$1.68B	$1.68B	$1.74B	$1.84B
Shareholders' equity	$732.70M	$790.70M	$998.40M	$1.12B	$1.21B	$1.33B	$1.46B	$1.38B	$1.52B	$1.30B	$1.42B	$1.58B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$45.20M	$87.60M	$86.80M	$108.30M	$147.50M	$63.80M	$196.50M	$125.70M	$183.30M	$113.80M	$88.40M	$123.50M
Capital expenditures	$29.30M	$22.10M	$22.50M	$26.70M	$53.60M	$12.30M	$18.60M	$25.60M	$135.10M	$24.30M	$32.50M	$57.10M
Free cash flow	$15.90M	$65.50M	$64.30M	$81.60M	$93.90M	$51.50M	$177.90M	$100.10M	$48.20M	$89.50M	$55.90M	$66.40M
Investing cash flow	-$31.60M	-$24.00M	-$24.90M	-$29.30M	-$68.00M	-$15.60M	-$23.30M	-$31.00M	-$152.80M	-$27.70M	-$37.40M	-$66.90M
Financing cash flow	$2.20M	-$14.10M	$8.80M	-$1.90M	-$20.80M	$277.70M	-$343.50M	-$457.00M	-$72.50M	-$319.90M	$4.00M	-$6.00M
Share buybacks	—	—	—	$0	$0	$0	$30.10M	$29.50M	$0	$300.00M	$0	$0
Stock-based compensation	$12.70M	$14.20M	$17.00M	$18.10M	$20.00M	$18.20M	$7.50M	$16.70M	$20.30M	$21.30M	$19.60M	$20.60M
Depreciation & amortization	$18.80M	$18.80M	$19.20M	$21.30M	$21.50M	$21.70M	$22.30M	$22.00M	$24.40M	$26.20M	$26.70M	$28.20M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.